Comparison of the effectiveness of various methods of surgical treatment of male urethral stricture
- 作者: Slynko T.N.1, Lavrushina O.M.1, Sidnyaev V.A.1
-
隶属关系:
- Moscow Financial and Industrial University “Synergy”
- 期: 卷 31, 编号 3 (2024)
- 页面: 66-70
- 栏目: Original articles
- URL: https://journal-vniispk.ru/2073-4034/article/view/262436
- DOI: https://doi.org/10.18565/pharmateca.2024.3.66-70
- ID: 262436
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
Background. Urethral strictures are a common urological disease characterized by narrowing of the lumen of the urethra, accompanied by a slower outflow of urine, pain in the perineum and lower back, possible dysfunction of sexual function, and the presence of micro- and macrohematuria. Urethroplasty (single-stage and stage-by-stage) using autologous grafts of buccal epithelium or part of the penis (dorsal part or skin flap) remains the “gold” standard in the treatment of urethral strictures (US). Despite the fact that considerable experience in urethroplasty has recently been accumulated, the risks of following complications remain: recurrence of strictures, development of fistulas, incontinence, deformation of the penis, bleeding from the graft collection site, etc. For this reason, attempts to create new and improve existing methods of surgical treatment SU continue. For example, urethroplasty using an acellular patch from bovine pericardium or a combined material with the addition of buccal epithelial cells are effective, but methods that are not available for widespread use. The success rate of using these materials varies from 58.2 to 88.9%. The effectiveness of drug-coated balloon dilatation is 67.0–74.6%, and the method itself may become widespread in the near future.
Objective. Comparison of the effectiveness of surgical treatment methods for male US.
Methods. We selected full-text articles published on the resources “PubMed” and “Scientific Electronic Library” in Russian or English on December 10, 2023 using the keywords: “urethra”, “stricture”, “urethral stricture”, “treatment of urethral stricture”, «urethroplasty», «tissue engineering». The selection criteria were: the topic of research on US and their treatment, tissue engineering, and the duration of the research less than 8 years.
Results. Our study showed that due to the great effectiveness of single-stage and stage-by-stage urethroplasty, internal optical urethrotomy and, despite the existing risks of dysfunction and shape of the penis, these methods remain leading among other methods of surgical treatment of male US.
作者简介
T. Slynko
Moscow Financial and Industrial University “Synergy”
Email: vitaliysidnyaev@mail.ru
ORCID iD: 0000-0001-5467-6530
俄罗斯联邦, Moscow
O. Lavrushina
Moscow Financial and Industrial University “Synergy”
Email: vitaliysidnyaev@mail.ru
俄罗斯联邦, Moscow
Vitaly Sidnyaev
Moscow Financial and Industrial University “Synergy”
编辑信件的主要联系方式.
Email: vitaliysidnyaev@mail.ru
ORCID iD: 0009-0002-5327-7794
Clinical Psychologist, Student of the Faculty of Medicine
俄罗斯联邦, Moscow参考
- Общероссийская общественная организация «Российское общество урологов». Клинические рекомендации «Стриктура уретры». 2021. [All-Russian public organization “Russian Society of Urologists”. Clinical recommendations “Urethra stricture”. 2021. (In Russ.)].
- European Association of Urology. Guidelines on Urethral Strictures. 2023.
- Chapman D., Kinnaird A., Rourke K. Independent Predictors of Stricture Recurrence Following Urethroplasty for Isolated Bulbar Urethral Strictures. J Urol. 2017;198(5):1107–12. doi: 10.1016/j.juro.2017.05.006.
- Han J.S., Liu J., Hofer M.D., et al. Risk of urethral stricture recurrence increases over time after urethroplasty. Int J Urol. 2015;22(7):695–99. doi: 10.1111/iju.12781.
- Yildirim H., Hennus P.M.L., Wyndaele M.I.A., de Kort L.M.O. Do previous urethral endoscopic procedures and preoperative self-dilatation increase the risk of stricture recurrence after urethroplasty? Low Urin Tract Symptoms. 2022;14(3):163–69. doi: 10.1111/luts.12419.
- Theisen K.M., Soubra A., Grove S., et al. Association Between Ejaculatory Dysfunction and Post-Void Dribbling After Urethroplasty. Urology. 2021;153:320–26. doi: 10.1016/j.urology.2021.04.016.
- Omar R.G., Khalil M.M., Alezaby H., et al. Evaluation of erectile function after anastomotic vs substitutional urethroplasty for bulbar urethral stricture. Arab J Urol. 2020;18(4):226–32. doi: 10.1080/2090598X.2020.1805965.
- Heinsimer K., Wiegand L. Erectile and Ejaculatory Dysfunction After Urethroplasty. Curr Urol Rep. 2021;22(4):19. doi: 10.1007/s11934-021-01039-9.
- Hoare D.T., Bekkema J., Rourke K.F. Prospective Assessment of Patient-perceived Short-term Changes in Penile Appearance After Urethroplasty. Urology. 2021;158:222–27. doi: 10.1016/j.urology.2021.08.021.
- Ortac M., Ekerhult T.O., Zhao W., Atala A. Tissue Engineering Graft for Urethral Reconstruction: Is It Ready for Clinical Application? Urol Res Pract. 2023;49(1):11–8. doi: 10.5152/tud.2023.22226.
- Grebenik E.A., Gafarova E.R., Istranov L.P., et al. Mammalian Pericardium-Based Bioprosthetic Materials in Xenotransplantation and Tissue Engineering. Biotechnol J. 2020;15(8):e1900334. doi: 10.1002/biot.201900334.
- Mandal T.K., Dhanuka S., Choudhury S., et al. Tissue engineered indigenous pericardial patch urethroplasty: A promising solution to a nagging problem. Asian J Urol. 2020;7(1):56–60. doi: 10.1016/j.ajur.2019.05.001.
- Choudhury S., Khare E., Pal D.K. Acellular Tissue Engineered Pericardial Patch Urethroplasty: A New Horizon of Substitution Urethroplasty. Turk J Urol. 2022;48(3):222–28. doi: 10.5152/tud.2022.22018.
- Gouya R.-L., Barbagli G., Heidenreich A., et al. Results of Use of Tissue-Engineered Autologous Oral Mucosa Graft for Urethral Reconstruction: A Multicenter, Prospective, Observational Trial. EBioMedicine. 2017;23:185–92. Foi: 10.1016/j.ebiom.2017.08.014.
- Ram-Liebig G., Bednarz J., Stuerzebecher B., et al. Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in Europe. Adv Drug Deliv Rev. 2015;82–83):181–91. doi: 10.1016/j.addr.2014.11.009.
- Satyagraha P., Alluza H.H.D., Indradiputra I.M.U., et al. TGF-β1 Effects on Total Collagen of the New Zealand Rabbit’s Urethral Wall (Oryctolagus cuniculus) in Animal Models of Urethral Stricture. Med Arch. 2023;77(3):189–93. doi: 10.5455/medarh.2023.77.189-193.
- Nikolavsky D., Manwaring J., Bratslavsky G., et al. Novel Concept and Method of Endoscopic Urethral Stricture Treatment Using Liquid Buccal Mucosal Graft. J Urol. 2016;196(6):1788–95. doi: 10.1016/j.juro.2016.05.028.
- Virasoro R., DeLong J.M., Estrella R.E., et al. A Drug-Coated Balloon Treatment for Urethral Stricture Disease: Three-Year Results from the ROBUST I Study. Res Rep Urol. 2022;14:177–83. doi: 10.2147/RRU.S359872.
- Elliott S.P., Coutinho K., Robertson K.J., et al. One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume® Drug-Coated Balloon for Anterior Urethral Strictures. J Urol. 2022;207(4):866–75. doi: 10.1097/JU.0000000000002346.
- Kelly L., Shore J., Wright J., et al. Economic evaluation of Optilume, a drug-coated balloon for recurrent anterior male urethral stricture. BJUI Compass. 2023;4(4):430–36. doi: 10.1002/bco2.241.
补充文件
